FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164096643> ?p ?o ?g. }

• W2164096643 endingPage "2898" @default.
• W2164096643 startingPage "2894" @default.
• W2164096643 abstract "To investigate whether the bleomycin sensitivity assay, an in vitro peripheral blood lymphocyte assay, can predict outcome in patients with inoperable stage III non-small-cell lung cancer (NSCLC) treated with definitive radiotherapy and chemotherapy.We identified 102 patients with inoperable stage III NSCLC cell lung cancer treated with definitive radiotherapy and chemotherapy. The patients' pretreatment peripheral blood lymphocyte cultures were treated with the radiomimetic mutagen bleomycin. An index of bleomycin sensitivity was determined by counting the number of chromatid breaks in 50 metaphases. The correlation between bleomycin sensitivity (expressed as mean breaks per cell) and clinical outcome was analyzed.High bleomycin sensitivity (defined as a mean of >1.02 chromatid breaks/cell, representing the third quartile of bleomycin sensitivity) predicted poor disease-specific survival and overall survival. The 6-year disease-specific survival was 27% in patients with high bleomycin sensitivity compared with 46% in patients without such sensitivity (P = 0.0094). The association remained statistically significant when adjusted for smoking status, age, and radiation dose. The 6-year overall survival was 19% for patients with high bleomycin sensitivity and 29% for those without (P = 0.0193). There was a trend toward worse local regional control and worse disease-free survival among patients with high bleomycin sensitivity. There was no difference between the two groups in distant metastasis-free survival or radiation treatment-related complications.High bleomycin sensitivity correlated with poor overall survival and disease-specific survival in these patients with stage III NSCLC treated with radiotherapy and chemotherapy. Bleomycin sensitivity may function as a biomarker for poor clinical outcome for this group of patients." @default.
• W2164096643 created "2016-06-24" @default.
• W2164096643 creator A5006430883 @default.
• W2164096643 creator A5008781374 @default.
• W2164096643 creator A5009466654 @default.
• W2164096643 creator A5012002845 @default.
• W2164096643 creator A5027718340 @default.
• W2164096643 creator A5034765756 @default.
• W2164096643 creator A5055888843 @default.
• W2164096643 creator A5066957198 @default.
• W2164096643 creator A5071173748 @default.
• W2164096643 creator A5077763767 @default.
• W2164096643 creator A5086483620 @default.
• W2164096643 date "2005-04-15" @default.
• W2164096643 modified "2023-09-27" @default.
• W2164096643 title "High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy" @default.
• W2164096643 cites W1579756024 @default.
• W2164096643 cites W1626822725 @default.
• W2164096643 cites W1977439202 @default.
• W2164096643 cites W2003361136 @default.
• W2164096643 cites W2014260980 @default.
• W2164096643 cites W2043696829 @default.
• W2164096643 cites W2062223022 @default.
• W2164096643 cites W2079620909 @default.
• W2164096643 cites W2081086432 @default.
• W2164096643 cites W2105483695 @default.
• W2164096643 cites W2113316373 @default.
• W2164096643 cites W2115250657 @default.
• W2164096643 cites W2118951956 @default.
• W2164096643 cites W2132142135 @default.
• W2164096643 cites W2152771893 @default.
• W2164096643 cites W2168168277 @default.
• W2164096643 cites W2168655513 @default.
• W2164096643 cites W2170909879 @default.
• W2164096643 cites W2267562868 @default.
• W2164096643 cites W2412152234 @default.
• W2164096643 cites W2109317141 @default.
• W2164096643 doi "https://doi.org/10.1158/1078-0432.ccr-04-2176" @default.
• W2164096643 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15837739" @default.
• W2164096643 hasPublicationYear "2005" @default.
• W2164096643 type Work @default.
• W2164096643 sameAs 2164096643 @default.
• W2164096643 citedByCount "10" @default.
• W2164096643 countsByYear W21640966432012 @default.
• W2164096643 crossrefType "journal-article" @default.
• W2164096643 hasAuthorship W2164096643A5006430883 @default.
• W2164096643 hasAuthorship W2164096643A5008781374 @default.
• W2164096643 hasAuthorship W2164096643A5009466654 @default.
• W2164096643 hasAuthorship W2164096643A5012002845 @default.
• W2164096643 hasAuthorship W2164096643A5027718340 @default.
• W2164096643 hasAuthorship W2164096643A5034765756 @default.
• W2164096643 hasAuthorship W2164096643A5055888843 @default.
• W2164096643 hasAuthorship W2164096643A5066957198 @default.
• W2164096643 hasAuthorship W2164096643A5071173748 @default.
• W2164096643 hasAuthorship W2164096643A5077763767 @default.
• W2164096643 hasAuthorship W2164096643A5086483620 @default.
• W2164096643 hasConcept C111337013 @default.
• W2164096643 hasConcept C121332964 @default.
• W2164096643 hasConcept C126322002 @default.
• W2164096643 hasConcept C142724271 @default.
• W2164096643 hasConcept C143998085 @default.
• W2164096643 hasConcept C146357865 @default.
• W2164096643 hasConcept C151730666 @default.
• W2164096643 hasConcept C185544564 @default.
• W2164096643 hasConcept C26114605 @default.
• W2164096643 hasConcept C2776232574 @default.
• W2164096643 hasConcept C2776256026 @default.
• W2164096643 hasConcept C2776694085 @default.
• W2164096643 hasConcept C509974204 @default.
• W2164096643 hasConcept C71924100 @default.
• W2164096643 hasConcept C86803240 @default.
• W2164096643 hasConcept C90924648 @default.
• W2164096643 hasConceptScore W2164096643C111337013 @default.
• W2164096643 hasConceptScore W2164096643C121332964 @default.
• W2164096643 hasConceptScore W2164096643C126322002 @default.
• W2164096643 hasConceptScore W2164096643C142724271 @default.
• W2164096643 hasConceptScore W2164096643C143998085 @default.
• W2164096643 hasConceptScore W2164096643C146357865 @default.
• W2164096643 hasConceptScore W2164096643C151730666 @default.
• W2164096643 hasConceptScore W2164096643C185544564 @default.
• W2164096643 hasConceptScore W2164096643C26114605 @default.
• W2164096643 hasConceptScore W2164096643C2776232574 @default.
• W2164096643 hasConceptScore W2164096643C2776256026 @default.
• W2164096643 hasConceptScore W2164096643C2776694085 @default.
• W2164096643 hasConceptScore W2164096643C509974204 @default.
• W2164096643 hasConceptScore W2164096643C71924100 @default.
• W2164096643 hasConceptScore W2164096643C86803240 @default.
• W2164096643 hasConceptScore W2164096643C90924648 @default.
• W2164096643 hasIssue "8" @default.
• W2164096643 hasLocation W21640966431 @default.
• W2164096643 hasLocation W21640966432 @default.
• W2164096643 hasOpenAccess W2164096643 @default.
• W2164096643 hasPrimaryLocation W21640966431 @default.
• W2164096643 hasRelatedWork W1535958986 @default.
• W2164096643 hasRelatedWork W1975025425 @default.
• W2164096643 hasRelatedWork W2357406576 @default.
• W2164096643 hasRelatedWork W2376593068 @default.
• W2164096643 hasRelatedWork W2390264150 @default.

• next